4 results
8-K
EX-10.1
FENC
Fennec Pharmaceuticals Inc
4 Feb 19
Fennec Pharmaceuticals Announces $12.5 Million Debt Financing with Bridge Bank
2:26pm
this Judicial Reference Provision.
12.2 With the exception of the items specified in Section 12.3, below, any controversy, dispute or claim (each … CONTROVERSY, DISPUTE OR CLAIM BETWEEN OR AMONG THEM ARISING OUT OF OR IN ANY WAY RELATED TO, THIS AGREEMENT OR THE OTHER LOAN DOCUMENTS.
13. General
20FR12B
EX-4.8
FENC
Fennec Pharmaceuticals Inc
17 Sep 04
Initial registration of securities (foreign private issuers)
12:00am
controversy or claim arising out of or relating to this Lease, or the breach thereof, be settled by arbitration in accordance with the Commercial Arbitration
20FR12B
EX-4.2
FENC
Fennec Pharmaceuticals Inc
17 Sep 04
Initial registration of securities (foreign private issuers)
12:00am
stability nor the good public perception or reputation of either party is threatened.
Negotiation
In any dispute, controversy or difference
20FR12B
EX-4.5
FENC
Fennec Pharmaceuticals Inc
17 Sep 04
Initial registration of securities (foreign private issuers)
12:00am
controversy or claim arising under this Agreement or a breach of this Agreement.
[SIGNATURES BEGIN ON NEXT PAGE.]
EXCLUSIVE LICENSE AGREEMENT
SIGNATURE PAGE
- Prev
- 1
- Next